Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call summary and Q&A indicate positive sentiment with raised revenue expectations, strong managed care customer performance, and optimistic guidance. The introduction of smart eyewear and strategic marketing shifts are expected to drive growth. Cost management and store refreshes further support a positive outlook. Despite some uncertainties and conservative guidance, the overall sentiment leans towards positive with potential for stock price appreciation.
Net Revenue (Fiscal 2025) $1.99 billion, a 9% increase year-over-year. This growth was driven by strong mid-single-digit comp store sales and initiatives focused on modernizing the business.
Adjusted Comparable Store Sales (Fiscal 2025) 6%, reflecting a healthy profit expansion and positive customer engagement.
Adjusted Operating Income (Fiscal 2025) $102.5 million, a 56% increase from $65.5 million in 2024. This was due to operating margin expansion of 160 basis points, reaching 5.2%.
Adjusted EPS (Fiscal 2025) $0.80, up from $0.52 in 2024, reflecting strong bottom-line results.
Net Revenue (Q4 2025) $503 million, a 15.1% increase year-over-year, supported by strong execution of initiatives and customer resilience.
Adjusted Comparable Store Sales (Q4 2025) 4.8%, driven by traffic growth in managed care, progressive, and outside Rx customers, along with strong average ticket growth.
Adjusted Operating Income (Q4 2025) $17.6 million, with AOI margin improving to 3.5% compared to 0.7% in Q4 2024. This was supported by pricing and merchandising initiatives.
Adjusted EPS (Q4 2025) $0.15 per share, compared to a loss of $0.04 per share in Q4 2024, reflecting improved profitability.
Average Ticket Growth (Fiscal 2025) 6%, driven by pricing and product mix improvements, particularly in managed care and premium frame offerings.
Managed Care Comp Sales (Fiscal 2025) Low double digits, contributing to 42% of total revenues, reflecting a shift towards more profitable customer cohorts.
Traffic Decline (Fiscal 2025) 0.5%, due to declines in self-pay customers, offset by gains in managed care and other profitable customer segments.
Gross Margin (Q4 2025) Increased by 40 basis points, driven by higher average ticket and managed care revenues.
Adjusted SG&A (Q4 2025) $251.9 million, with a leverage of 180 basis points, driven by lower advertising and associate-related expenses.
Operating Cash Flow (Fiscal 2025) $146.3 million, reflecting strong cash generation.
Capital Expenditures (Fiscal 2025) $72.8 million, primarily for new and existing stores and IT investments.
Meta AI glasses: Launched in spring, exceeded expectations with sell-through. Available in 300 stores as of Q4, with plans to expand to all stores by Q2 2026.
Premium frames and branded assortments: Shifted towards more premium frames and branded assortments, increasing frames priced above $99 from 20% to 40% by year-end.
Lens leadership initiative: Introduced premium lenses, including Stellest for myopia and Tier 4 progressive lenses. Plans to increase premium lens mix to 60% by 2026.
Customer base expansion: Targeted more profitable customer cohorts such as managed care, progressive lenses, and outside Rx users. Managed care comp sales grew low double digits, contributing to 42% of revenues.
New store growth: Opened 12 new America's Best stores in Q4, with plans for 30-35 new stores in 2026, primarily under the America's Best brand.
Operational efficiencies: Achieved 160 basis points operating margin expansion in 2025. Implemented cost savings plan with $10 million annualized savings expected in 2026.
Technology modernization: Launched Oracle ERP platform and Adobe Digital Experience platform in 2025, with further integration planned for 2026.
Brand transformation: Redefined America's Best brand with a new logo and campaign, 'Every Eye Deserves Better,' leading to increased unaided brand awareness.
Consultative selling model: Implemented a consultative selling model, supported by digital tools like iPads, to enhance customer engagement and increase average ticket size.
Customer Traffic Decline: Overall customer traffic declined by 2.5% in Q4 2025, with a 0.5% decline for the year. This was attributed to a shift in focus towards more profitable customer cohorts, which led to attrition among less profitable self-pay customers.
Supply Chain and Operational Costs: The company experienced slight increases in optometrist-related costs and healthcare expenses, which could impact profitability if not managed effectively.
Weather Challenges: Weather events in early 2026 have already impacted comp store sales, posing a risk to achieving sales targets.
Macroeconomic and Consumer Demand Uncertainty: The 2026 outlook considers a range of scenarios for macroeconomic conditions and consumer demand, indicating potential risks from economic uncertainties.
Store Closures: The company plans to close 10 to 15 stores in 2026 as part of fleet optimization, which could lead to short-term revenue loss and operational challenges.
Technology and Modernization Investments: Significant investments in technology, including ERP and CRM systems, are critical for modernization but could pose risks if implementation challenges arise or if ROI is not achieved.
Managed Care Revenue Dependency: A significant portion of revenue growth is attributed to managed care customers. Over-reliance on this segment could pose risks if there are changes in managed care policies or customer behavior.
Product and Pricing Strategy Risks: The shift towards premium products and pricing strategies may alienate price-sensitive customers, potentially impacting traffic and sales.
Revenue Expectations: For fiscal 2026, National Vision expects net revenue between $2.03 billion and $2.09 billion, supported by adjusted comparable store sales growth of 3% to 6%.
Profitability Projections: Adjusted operating income is expected to be between $107 million and $133 million, with adjusted operating margin expansion of approximately 100 basis points relative to fiscal 2025, excluding the 53rd week.
Earnings Per Share (EPS): Adjusted diluted EPS is projected to be between $0.85 and $1.09 per share.
Capital Expenditures: Capital expenditures are expected to be between $73 million and $78 million, including investments in new stores and technology.
Store Growth: The company plans to open approximately 30 to 35 new stores in 2026, with net new store growth of approximately 20 to 25 stores after accounting for closures.
Product and Pricing Strategy: In 2026, the company plans to simplify lens pricing and insurance pricing constructs, introduce premium lenses, and expand branded frame assortments to 70% in stores.
Customer Experience Enhancements: The company will continue to implement a consultative selling model, enhance in-store digital tools, and tailor product assortments to local customer profiles.
Technology Investments: Plans include expanding the Adobe Digital Experience platform across all brands, integrating Adobe CRM capabilities, and launching expanded Oracle ERP capabilities.
Share Repurchase Authorization: The Board of Directors approved a new share repurchase authorization following the expiration of the prior authorization on January 3. The new authorization allows for the repurchase of up to $50 million of shares until December 28, 2030.
The earnings call summary and Q&A indicate positive sentiment with raised revenue expectations, strong managed care customer performance, and optimistic guidance. The introduction of smart eyewear and strategic marketing shifts are expected to drive growth. Cost management and store refreshes further support a positive outlook. Despite some uncertainties and conservative guidance, the overall sentiment leans towards positive with potential for stock price appreciation.
The earnings call highlights several positive factors: raised revenue outlook, expected gross margin expansion, and optimistic customer trends, especially in managed care and premium segments. Despite some deceleration in Q4 growth due to macro uncertainties, the company's strategic initiatives, such as new store openings and CRM platform launch, indicate future growth. Analysts' questions reflected confidence, with no significant competitive losses noted. The positive sentiment is further reinforced by the success of Meta glasses and brand awareness growth. Overall, the company's strong financial metrics and strategic positioning suggest a positive stock price movement.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.